Live News EARNINGS ARTICLE L impact Jul 28, 2026, 08:06 PM UTC

NeoGenomics Raises FY2026 Sales Guidance from $797.000M-$803.000M to $802.000M-$806.000M vs $800.433M Est

NeoGenomics (NASDAQ: NEO ) raises FY2026 sales outlook from $797.000 million-$803.000 million to $802.000 million-$806.000 million vs $800.433 million estimate.

NEO

SquawkNews Newsroom

NeoGenomics (NASDAQ: NEO ) raises FY2026 sales outlook from $797.000 million-$803.000 million to $802.000 million-$806.000 million vs $800.433 million estimate.